Form 4 Tracker
JOHNSON & JOHNSON
JNJ

47 insider filings · Latest: Jun 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 11, 2026Jun 12 9:23 PMKathryn E WengelEVP, Chief TO and Risk Officer
Sale
10,000$241.15$2.4M114,287.874(D)

View →

Jun 11, 2026Jun 11 5:44 PMWengel Kathryn E
Proposed Sale
10,000$240.15$2.4M

View →

Feb 27, 2026Mar 3 9:21 PMRobert J DeckerVP Corporate Controller
Sale
4,075$247.87$1.0M23,682(D)

View →

Feb 27, 2026Feb 27 7:35 PMDecker Robert J
Proposed Sale
4,075$247.87$1.0M

View →

Feb 20, 2026Feb 23 10:20 PMTimothy SchmidEVP, WW Chair, MedTech
Sale
1,322$245.66$324.8K25,447(D)

View →

Feb 20, 2026Feb 20 3:46 PMSchmid Timothy
Proposed Sale
1,322$245.66$324.8K

View →

Feb 17, 2026Feb 19 2:12 AMJames D. SwansonEVP, CIO
Sale
20,521$242.70$5.0M25,698.131(D)

View →

Feb 13, 2026Feb 19 2:12 AMJames D. SwansonEVP, CIO
Sale
41,559$243.73$10.1M25,020.131(D)

View →

Feb 17, 2026Feb 19 2:12 AMJoseph J WolkExec VP, CFO
Sale
89,654$242.80$21.8M14,000(D)

View →

Feb 17, 2026Feb 19 2:12 AMREED JOHN CEVP, Innovative Medicine, R&D
Sale
53,931$243.00$13.1M10,658(D)

View →

Feb 18, 2026Feb 19 2:11 AMTimothy SchmidEVP, WW Chair, MedTech
Sale
22,623$244.33$5.5M26,769(D)

View →

Feb 17, 2026Feb 19 2:11 AMVanessa BroadhurstEVP, Global Corp Affairs
Sale
6,197$243.39$1.5M23,003(D)

View →

Feb 18, 2026Feb 18 4:14 PMSchmid Timothy
Proposed Sale
22,623$244.33$5.5M

View →

Feb 17, 2026Feb 17 9:10 PMBroadhurst Vanessa
Proposed Sale
6,197$243.39$1.5M

View →

Feb 17, 2026Feb 17 7:52 PMSwanson James D.
Proposed Sale
20,521$242.70$5.0M

View →

Feb 17, 2026Feb 17 7:43 PMWolk Joseph J
Proposed Sale
89,654$242.80$21.8M

View →

Feb 17, 2026Feb 17 5:44 PMREED JOHN C
Proposed Sale
53,931$243.00$13.1M

View →

Feb 13, 2026Feb 13 7:33 PMSwanson James D.
Proposed Sale
41,559$243.73$10.1M

View →

Feb 5, 2026Feb 5 9:31 PMForminard Elizabeth
Proposed Sale
6,226$237.90$1.5M

View →

Jan 26, 2026Jan 28 11:07 PMJoaquin DuatoDirector, CEO and Chairman of the Board
Sale
100,000$221.23$22.1M30,852(I)

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 11, 2026Jun 12 9:23 PMKathryn E WengelEVP, Chief TO and Risk Officer
Option Exercise
10,000$115.6732,965(D)

View →

Jun 9, 2026Jun 11 8:56 PMEugene A. WoodsDirector
Grant/Award
161.0896,411.959(D)

View →

Jun 9, 2026Jun 11 8:43 PMDaniel E PintoDirector
Grant/Award
134.2412,320.824(D)

View →

Jun 9, 2026Jun 11 8:35 PMMarillyn A HewsonDirector
Grant/Award
214.78615,791.877(D)

View →

May 1, 2026May 4 8:58 PMREED JOHN CEVP, Innovative Medicine, R&D
Option Exercise
25,2550(D)

View →

Apr 23, 2026Apr 27 10:23 PMEugene A. WoodsDirector
Grant/Award
9756,215.094(D)

View →

Apr 23, 2026Apr 27 10:21 PMNadja WestDirector
Grant/Award
9757,730.049(D)

View →

Apr 23, 2026Apr 27 10:17 PMMark A WeinbergerDirector
Grant/Award
97512,010.408(D)

View →

Apr 23, 2026Apr 27 10:13 PMDaniel E PintoDirector
Grant/Award
1,7122,174.069(D)

View →

Apr 23, 2026Apr 27 10:12 PMJohn G MorikisDirector
Grant/Award
1,5401,540(D)

View →

Apr 23, 2026Apr 27 10:06 PMMark B. McclellanDirector
Grant/Award
97521,278.593(D)

View →

Apr 23, 2026Apr 27 10:05 PMHubert JolyDirector
Grant/Award
9759,183.605(D)

View →

Apr 23, 2026Apr 27 10:01 PMPaula A JohnsonDirector
Grant/Award
9755,359.397(D)

View →

Apr 23, 2026Apr 27 9:48 PMMarillyn A HewsonDirector
Grant/Award
97515,487.939(D)

View →

Apr 23, 2026Apr 27 9:43 PMJennifer A DoudnaDirector
Grant/Award
97510,899.171(D)

View →

Apr 23, 2026Apr 27 9:38 PMMary C BeckerleDirector
Grant/Award
97516,797.739(D)

View →

Mar 10, 2026Mar 13 1:31 AMMarillyn A HewsonDirector
Grant/Award
206.49214,512.94(D)

View →

Mar 4, 2025Mar 13 1:31 AMMarillyn A HewsonDirector
Grant/Award
75.25614,306.449(D)

View →

Mar 10, 2026Mar 13 12:39 AMDaniel E PintoDirector
Grant/Award
129.058462.069(D)

View →

Mar 10, 2026Mar 13 12:37 AMEugene A. WoodsDirector
Grant/Award
154.8695,240.094(D)

View →

Page 1 of 4

Next →